Rating History for GT Biopharma Inc. (GTBP) by Roth/MKM
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 12/2/2024 | Jonathan Aschoff | New Coverage | Buy (N/A) |
11.00 (N/A) |
2.86 (0.46) |
-83.92% | Details |
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 12/2/2024 | Jonathan Aschoff | New Coverage | Buy (N/A) |
11.00 (N/A) |
2.86 (0.46) |
-83.92% | Details |
![]() |
|||||||
![]() |
|||||||